Cannabidiol (Epidyolex) approved in Scotland for individuals living with Dravet Syndrome, a life-limiting epilepsy
Posted 7th September 2020 in News
DSUK welcomes the availability of Epidyolex via NHS Scotland as a treatment option for individuals living with Dravet Syndrome